Agency Information Collection Activities: Submission for OMB Review; Comment Request, 82032-82033 [2010-32708]

Download as PDF srobinson on DSKHWCL6B1PROD with NOTICES 82032 Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices MD 20993–0002, 301–796–9001, FAX: 301–847–8533, email: kristine.khuc@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. Agenda: On March 8, 2011, the committee will discuss new drug application (NDA) 022–383, indacaterol maleate (ARCAPTA NEOHALER), by Novartis Pharmaceuticals Corp., for the long-term once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at http://www.fda.gov/ AdvisoryCommittees/Calendar/ default.htm. Scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before February 22, 2011. Oral presentations from the public will be scheduled between approximately 1 p.m. to 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before February VerDate Mar<15>2010 02:10 Dec 29, 2010 Jkt 223001 11, 2011. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by February 14, 2011. Persons attending FDA’s advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Kristine T. Khuc at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/ AdvisoryCommittees/ AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: December 21, 2010. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2010–32735 Filed 12–28–10; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301) 443– 1129. The following request has been submitted to OMB for review under the Paperwork Reduction Act of 1995: Proposed Project: Ryan White HIV/ AIDS Program Allocation and Expenditure Forms (OMB No. 0915– 0318)—[Extension] The Ryan White HIV/AIDS Program Allocation and Expenditure Reports will enable the Health Resources and Services Administration’s HIV/AIDS Bureau to track spending requirements for each program as outlined in the legislation. Grantees funded under Parts A, B, C, and D of the Ryan White HIV/ AIDS Program (codified under Title XXVI of the Public Health Service Act) would be required to report financial data to HRSA at the beginning and end of their grant cycle. All parts of the Ryan White HIV/AIDS Program specify HRSA’s responsibilities in the administration of grant funds. Accurate allocation and expenditure records of the grantees receiving Ryan White HIV/AIDS Program funding are critical to the implementation of the legislation and thus are necessary for HRSA to fulfill its responsibilities. The forms would require grantees to report on how funds are allocated and spent on core and non-core services, and on various program components, such as administration, planning, evaluation, and quality management. The two forms are identical in the types of information that are collected. However, the first report would track the allocation of the award at the beginning of the grant cycle and the second report would track actual expenditures (including carryover dollars) at the end of the grant cycle. The primary purposes of these forms are to (1) provide information on the number of grant dollars spent on various services and program components, and (2) oversee compliance with the intent of Congressional appropriations in a timely manner. In addition to meeting the goal of accountability to the Congress, clients, advocacy groups, and the general public, information collected on these reports is critical for HRSA, state and local grantees, and individual providers for the evaluation of the effectiveness of these programs. The response burden for grantees is estimated as: E:\FR\FM\29DEN1.SGM 29DEN1 82033 Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices Number of grantee respondents Program under which grantee is funded Part Part Part Part Part Part Responses per grantee Total responses Hours to complete each form Total hours A ................................................................................... B ................................................................................... A MAI ........................................................................... B MAI ........................................................................... C ................................................................................... D ................................................................................... 56 59 56 59 361 90 2 2 2 2 2 2 112 118 112 118 722 180 8 12 4 4 7 7 896 1416 448 472 5054 1260 Total .............................................................................. 681 ........................ 1,362 ........................ 9,546 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this Federal Register Notice to the desk officer for HRSA, either by e-mail to OIRA_submission@omb.eop.gov or by fax to 202–395–6974. Please direct all correspondence to the ‘‘attention of the desk officer for HRSA.’’ Dated: December 22, 2010. Robert Hendricks, Director, Division of Policy and Information Coordination. [FR Doc. 2010–32708 Filed 12–28–10; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSKHWCL6B1PROD with NOTICES National Institute of Dental and Craniofacial Research; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Dental and Craniofacial Research Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 02:10 Dec 29, 2010 Jkt 223001 Name of Committee: National Advisory Dental and Craniofacial Research Council. Date: January 24, 2011. Open: 8:30 a.m. to 11:30 a.m. Agenda: Report to the Director, NIDCR. Place: National Institutes of Health, Building 31C, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Closed: 1 p.m. to Adjournment. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31C, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Alicia J. Dombroski, PhD, Director, Division of Extramural Activities, Natl. Inst. of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892. Information is also available on the Institute’s/Center’s home page: http:// www.nidcr.nih.gov/about, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: December 21, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–32746 Filed 12–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel. Application of ‘‘Omics’’ Technologies in Tissue Samples. Date: January 18, 2011. Time: 9:30 a.m. to 10:45 a.m. Agenda: To review and evaluate contract proposals. Place: NIEHS/National Institutes of Health Sciences, Keystone Bldg., 530 Davis Drive, Research Triangle Park, NC 27709. (Telephone Conference Call). Contact Person: RoseAnne M McGee, Associate Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709. (919) 541–0752. mcgee1@niehs.nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel. High Throughput Screening for Reactive Oxygen Species. Date: January 18, 2011. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate contract proposals. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. (Telephone Conference Call). Contact Person: RoseAnne M McGee, Associate Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709. (919) 541–0752. mcgee1@niehs.nih.gov. Name of Commitee: National Institute of Environmental Health Sciences Special Emphasis Panel. In Vitro 3–D Tissue Models for Toxicity Testing. Date: January 18, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: NIEHS/National Institutes of Health, Keystone Bldg., 530 Davis Drive, Research Triangle Park, NC 27709. (Telephone Conference Call). Contact Person: RoseAnne M McGee, Associate Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 75, Number 249 (Wednesday, December 29, 2010)]
[Notices]
[Pages 82032-82033]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32708]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Health Resources and Services Administration 
(HRSA) publishes abstracts of information collection requests under 
review by the Office of Management and Budget (OMB), in compliance with 
the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). To request 
a copy of the clearance requests submitted to OMB for review, e-mail 
paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301) 
443-1129.
    The following request has been submitted to OMB for review under 
the Paperwork Reduction Act of 1995:

Proposed Project: Ryan White HIV/AIDS Program Allocation and 
Expenditure Forms (OMB No. 0915-0318)--[Extension]

    The Ryan White HIV/AIDS Program Allocation and Expenditure Reports 
will enable the Health Resources and Services Administration's HIV/AIDS 
Bureau to track spending requirements for each program as outlined in 
the legislation. Grantees funded under Parts A, B, C, and D of the Ryan 
White HIV/AIDS Program (codified under Title XXVI of the Public Health 
Service Act) would be required to report financial data to HRSA at the 
beginning and end of their grant cycle.
    All parts of the Ryan White HIV/AIDS Program specify HRSA's 
responsibilities in the administration of grant funds. Accurate 
allocation and expenditure records of the grantees receiving Ryan White 
HIV/AIDS Program funding are critical to the implementation of the 
legislation and thus are necessary for HRSA to fulfill its 
responsibilities.
    The forms would require grantees to report on how funds are 
allocated and spent on core and non-core services, and on various 
program components, such as administration, planning, evaluation, and 
quality management. The two forms are identical in the types of 
information that are collected. However, the first report would track 
the allocation of the award at the beginning of the grant cycle and the 
second report would track actual expenditures (including carryover 
dollars) at the end of the grant cycle.
    The primary purposes of these forms are to (1) provide information 
on the number of grant dollars spent on various services and program 
components, and (2) oversee compliance with the intent of Congressional 
appropriations in a timely manner. In addition to meeting the goal of 
accountability to the Congress, clients, advocacy groups, and the 
general public, information collected on these reports is critical for 
HRSA, state and local grantees, and individual providers for the 
evaluation of the effectiveness of these programs.
    The response burden for grantees is estimated as:

[[Page 82033]]



----------------------------------------------------------------------------------------------------------------
                                     Number of                                       Hours to
 Program under which grantee is       grantee      Responses per       Total       complete each    Total hours
             funded                 respondents       grantee        responses         form
----------------------------------------------------------------------------------------------------------------
Part A..........................              56               2             112               8             896
Part B..........................              59               2             118              12            1416
Part A MAI......................              56               2             112               4             448
Part B MAI......................              59               2             118               4             472
Part C..........................             361               2             722               7            5054
Part D..........................              90               2             180               7            1260
                                 -------------------------------------------------------------------------------
    Total.......................             681  ..............           1,362  ..............           9,546
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent within 30 days of this Federal 
Register Notice to the desk officer for HRSA, either by e-mail to 
OIRA_submission@omb.eop.gov or by fax to 202-395-6974. Please direct 
all correspondence to the ``attention of the desk officer for HRSA.''

    Dated: December 22, 2010.
Robert Hendricks,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-32708 Filed 12-28-10; 8:45 am]
BILLING CODE 4165-15-P